D. E. Shaw & Co., Inc. Bionano Genomics, Inc. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.36 - $36.0 $96,381 - $9.64 Million	267,726 Added 2350.54%	279,116 $511,000
Q2 2022 Aug 15, 2022	SELL	$12.3 - $27.3 $5.02 Million - $11.1 Million	-408,316 Reduced 97.29%	11,390 $16,000
Q1 2022 May 16, 2022	BUY	$16.6 - $32.3 $6.13 Million - $11.9 Million	369,220 Added 731.33%	419,706 $1.08 Million
Q4 2021 Feb 14, 2022	BUY	$29.9 - $61.2 $1.51 Million - $3.09 Million	50,486 New	50,486 $151,000
Q3 2021 Nov 15, 2021	SELL	$51.4 - $68.2 $570,334 - $756,747	-11,096 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$44.1 - $84.0 $489,333 - $932,064	11,096 New	11,096 $81,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $63.8M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.